At a glance
ClinicalIndex Comparison RecordN/ACompleted· 24 enrolled
Drug / intervention
Neurofeedback +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Therapeutic Efficacy of Frontal EEG Asymmetry Neurofeedback in Depression
In Brief
A clinical study evaluating Neurofeedback and Psychotherapy placebo for Depression. Completed, enrolled 24 participants across 1 site.
Detailed Summary
The investigators examined the therapeutic efficacy of neurofeedback in depression subjects. The investigators hypothesize that 5 weeks neurofeedback training will be able to alleviate depressive symptoms.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesSouth Korea
CollaboratorsKorea Research Foundation, Kyunghee University
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2006
Primary CompletionDec 2006
Study CompletionJan 2007
First PostedAug 2008
TodayJul 2026
First PostedAug 7, 2008
Enrollment StartSep 1, 2006
Primary CompletionDec 1, 2006
Study CompletionJan 1, 2007
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 17.9 years ago
Interventions
Neurofeedbackbehavioral
enhance relative activity level of left frontal activity
Psychotherapy placebobehavioral
These sessions consisted of additional assessment, interpretation of the test results and providing information on course and treatment of mood disorder.